slides · global inventory
Present Solution
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 24,547
Current window 16,351-16,380
Pages 819
Rows per page 30
Slide function
16,351-16,380 of 24,547
05
Includes a cartoon mascot at the bottom.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
08
The slide uses a molecular biology diagram to illustrate the structural difference in the binding domain of the NXC-201 therapy compared to competitors.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
09
Includes comparative bar charts and flow cytometry data.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · InterestLoop · Aha Moment1 hit
19
The slide uses a side-by-side comparison structure to explain two distinct but complementary technology platforms.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
35
Includes scientific diagrams of molecular pathways and efficacy charts.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Desire1 hit
45
The slide uses a process-flow style layout to connect platform capabilities to specific therapeutic assets.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Desire1 hit
46
The slide uses a process-like structure to map the platform pillars to specific product outputs.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
47
Includes technical diagrams of the drug molecule, comparative histology, and survival curves.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
49
The slide uses a combination of mechanism-of-action diagrams and clinical/preclinical data charts to validate the therapeutic approach.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
05
The slide uses a process-oriented layout to show four strategic pillars leading to a unified outcome.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Early Struggles1 hit
08
Uses a before-after framework to illustrate strategic evolution.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Early StrugglesLoop · Before After1 hit
08
Uses a brain diagram to map specific therapeutic areas to clinical evidence points.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
Uses scientific visualization to illustrate the drug's impact on brain function.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
The slide uses a process flow diagram to illustrate the biological mechanism of action.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
The slide uses a linear process flow to describe the clinical care delivery model.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
21
The slide uses a biological process diagram to explain the drug's mechanism of action (MOA).MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
23
The slide uses a bar chart to demonstrate the therapeutic index advantage of the R-enantiomer.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
26
The slide highlights three pillars of collaboration: discovery engine, drug delivery, and clinical testing.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
27
The slide highlights a strategic partnership and the resulting research pipeline.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
05
The slide uses a product photo to demonstrate the scale and form factor of the device.Nemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations Beat · ProductLoop · Logic Chain1 hit
10
The slide highlights the UI/UX of the companion app for the sugarBEAT CGM device.Nemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations 1 hit
18
Nemaura Medical | Investor Presentation Deck | 22 slidesNemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations 1 hit
20
Nemaura Medical | Investor Presentation Deck | 22 slidesNemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations 1 hit
08
Includes a detailed biological mechanism diagram showing the interaction of KOR, dynorphin, and neurotransmitters.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank Beat · Solution1 hit
17
Includes a biological pathway diagram showing V1aR antagonism and downstream signaling effects.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
19
The slide uses a biological pathway diagram to illustrate the mechanism of action of the drug candidate.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
21
The slide uses a biological pathway diagram to illustrate the mechanism of action (PAM) and the pathology of schizophrenia.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
22
Includes a biological mechanism diagram showing the inhibition of TDP-43 phosphorylation by NMRA-CK1δ.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
23
MVAE stands for Multimodal Variational Autoencoder.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
24
The slide uses a biological pathway diagram to illustrate the mechanism of action of the drug candidate.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit